Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Mol Genet Metab. 2011 Jul 12;104(3):383–389. doi: 10.1016/j.ymgme.2011.07.007

Figure 4.

Figure 4

One-way sensitivity analysis of incremental cost per quality-adjust life year (QALYs) as function of A) prevalence, B) test sensitivity, C) test specificity, D) cost of screening test and E) cost of confirmation and diagnostic testing; and F) the ratio of cost of BMTlate vs. BMTearly (cost BMTlate/cost BMTearly).